Investing Profile

Sebastian Kreuz

InvestorVC
Executive Director / Investment Manager at Boehringer Ingelheim Venture Fund
Photo of Sebastian Kreuz, Managing Director at Boehringer Ingelheim Venture Fund
cb
$3.3M - $17.0M
$8.5M
2
CompanyStageDateRound SizeTotal Raised
smartbax
SeedMay 2023$1M
$1M
Centauri Therapeutics
Series AFeb 2022$33M
$33M
Co-investors: Johannes Zanzinger (Boehringer Ingelheim Venture Fund)